The HiLo trial: a multicentre randomised trial of high- versus low-dose radioiodine, with or without recombinant human thyroid stimulating hormone, for remnant ablation after surgery for differentiated thyroid cancer

Clin Oncol (R Coll Radiol). 2008 Jun;20(5):325-6. doi: 10.1016/j.clon.2008.03.010.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Hormones / administration & dosage*
  • Humans
  • Iodine Radioisotopes / administration & dosage*
  • Multicenter Studies as Topic
  • Randomized Controlled Trials as Topic*
  • Thyroid Neoplasms / pathology
  • Thyroid Neoplasms / radiotherapy*
  • Thyroid Neoplasms / therapy
  • Thyroidectomy
  • Thyrotropin / administration & dosage*

Substances

  • Hormones
  • Iodine Radioisotopes
  • Thyrotropin